BRIEF-AstraZeneca pricing new severe asthma drug Fasenra below rivals

* Says pricing Fasenra below the treatment cost of all other biologics in severe asthma

Read more...
Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

BRIEF-Nav Canada reports October traffic figures

* Nav Canada - ‍air traffic in October 2017 increased by an average of 5.9 per cent compared to same month in 2016​ Source text for Eikon: Further company coverage:

0 0

Whoops, looks like something went wrong.